Quality-of-life issues in psoriasis

Dermatologic Clinics

Volumn 22, Issue 4, 2004, Pages 389-395

  Mukhtar, Rita ^a   Choi, Jane ^a   Koo, John Y M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

AWARENESS; DISEASE SEVERITY; FINANCIAL MANAGEMENT; HEALTH CARE COST; HUMAN; MEDICAL RESEARCH; MENTAL HEALTH; MORBIDITY; PRIORITY JOURNAL; PSORIASIS; QUALITY OF LIFE; REIMBURSEMENT; REVIEW; SOCIAL INTERACTION;

ADAPTATION, PSYCHOLOGICAL; CHRONIC DISEASE; COMBINED MODALITY THERAPY; FEMALE; HUMANS; INTERPERSONAL RELATIONS; MALE; PROGNOSIS; PSORIASIS; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SICKNESS IMPACT PROFILE; SOCIOECONOMIC FACTORS; STRESS, PSYCHOLOGICAL;

EID: 4344640344     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.det.2004.03.016     Document Type: Review

References (45)

1. Wahl A., Gjengedal E., Hanestad B. The bodily suffering of living with psoriasis: in-depth interviews with 22 hospitalized patients with psoriasis. Qual Health Res. 12(2):2002;250-261
2. Mazzetti M., Mozzetta A., Soavi G.C., Andreoli E., Foglio Bonda P.G., Puddu P., et al. Psoriasis, stress and psychiatry: psychodynamic characteristics of stressors. Acta Derm Venereol [Stockh]. 186(Suppl):1994;62-64
3. Jemec G.B.E., Wulf H.C. Patient-physician consensus on quality of life in dermatology. Clin Exp Dermatol. 21:1996;177-179
4. Krueger G., Koo J., Lebwohl M., Menter A., Stern R.S., Rolstad T. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol. 137(3):2001;280-284
5. Koo J. Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment. Dermatol Clin. 14(3):1996;485-496
6. McKenna K.E., Stern R.S. The outcomes movement and new measures of the severity of psoriasis. J Am Acad Dermatol. 34(3):1996;534-537
7. Ashcroft D.M., Li Wan Po A., Williams H.C., Griffiths C.E. Quality of life measures in psoriasis: a critical appraisal of their quality. J Clin Pharm Ther. 23(5):1998;391-398
8. Krueger G., Feldman S., Camisa C., Duvic M., Elder J., Gottlieb A., et al. Two considerations for patients with psoriasis and their clinicians: What defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis? J Am Acad Dermatol. 43(2):2000;281-285
9. Finlay A.Y., Khan G.K. Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol. 19(3):1994;210-216
10. Ashcroft D.M., Li Wan Po A., Williams H.C., Griffiths C.E. Clinical measures of disease severity and outcome in psoriasis: a critical appraisal of their quality. Br J Dermatol. 141:1999;185-191
11. Wahl A., Loge J., Wiklund I., Hanestad B. The burden of psoriasis: a study concerning the health-related quality of life among Norwegian adult patients with psoriasis compared with general population norms. J Am Acad Dermatol. 43(5):2000;803-808
12. Ware J.E., Snow K.K., Kosinski M., Gandek P. SF-36 Health Survey manual and interpretation guide. 1993;The Health Institute. New England: Medical Center, Boston
13. Badia X., Mascaro J.M., Lozano R. Measuring health-related quality of life in patients with mild to moderate eczema and psoriasis: clinical validity, reliability, and sensitivity to change of the DLQI. Br J Dermatol. 141:1999;698-702
14. Morgan M., McCreedy R., Simpson J., Hay R.J. Dermatology quality of life scales - a measure of the impact of skin diseases. Br J Dermatol. 136:1997;202-206
15. Finlay A.Y., Kelly S.E. Psoriasis - an index of disability. Clin Exp Dermatol. 12:1987;8-11
16. Kent G., Al-Abadie M. The Psoriasis Disability Index - further analyses. Clin Exp Dermatol. 18:1993;414-416
17. Koo J., Menter A., Lebwohl M., et al. The relationship between quality of life and disease severity: results from a large cohort of mild, moderate, and severe psoriasis patients [abstract]. Br J Dermatol. 147:2002;1078
18. st Annual Meeting of the American Academy of Dermatology. San Francisco, March 21-26, 2003
19. Koo J., Kosma C.M., Reinke K. The development of a disease-specific questionnaire to assess quality of life for psoriasis patients: an analysis of the reliability, validity, and responsiveness of the psoriasis quality of life questionnaire. Dermatol Psychosom. 3:2002;171-179
20. Fortune D.G., Richards H.L., Main C.J., Griffiths C.E. What patients with psoriasis believe about their condition. J Am Acad Dermatol. 39:1998;196-201
21. Rapp S.R., Feldman S.R., Exum M.L., Fleischer A.B. Jr., Reboussin D.M. Psoriasis causes as much disability as other major medical illnesses. J Am Acad Dermatol. 41(3 pt 1):1999;401-407
22. de Arruda L.H.F., de Moraes A.P.F. The impact of psoriasis on quality of life. Br J Dermatol. 144(Suppl 58):2001;33-36
23. Leary M.R., Rapp S.R., Herbst K.C., Exum M.L., Feldman S.R. Interpersonal concerns and psychological difficulties of psoriasis patients: effects of disease severity and negative evaluation. Health Psychol. 17(6):1998;530-553
24. Fried R.G., Friedman S., Paradis C., et al. Trivial or terrible? The psychosocial impact of psoriasis. Int J Dermatol. 34(2):1995;101-105
25. McKenna K.E., Stern R.S. The impact of psoriasis on the quality of life of patients from the 16-center PUVA follow-up cohort. J Am Acad Dermatol. 36(3 pt 1):1997;388-394
26. Zachariae R., Zachariae H., Blomqvist K., Davidsson S., Molin L., Mork C., et al. Quality of life in 6497 Nordic patients with psoriasis. Br J Dermatol. 146:2002;1006-1016
27. Devrimci-Ozguven H., Kundakci N., Kumbasar H., Boyvat A. The depression, anxiety, life satisfaction and affective expression levels in psoriasis patients. J Eur Acad Dermatol Venereol. 14:2000;267-271
28. Harvima R.J., Viinmaki H., Harvima I.T., Naukkarinen A., Savolainen L., Aalto M., et al. Association of psychic stress with clinical severity and symptoms of psoriatic patients. Acta Derm Venereol [Stockh]. 76:1996;467-471
29. Griffiths C.E., Richards H.L. Psychological influences in psoriasis. Clin Exp Dermatol. 26(4):2001;338-342
30. Gupta M.A., Gupta A.K. Depression and suicidal ideation in dermatology patients with acne, alopecia, atopic dermatitis and psoriasis. Br J Dermatol. 139:1998;846-850
31. Finlay A.Y., Coles E.C. The effect of severe psoriasis on the quality of life of 369 patients. Br J Dermatol. 132:1995;236-244
32. Lundberg L., Johannesson M., Silverdahl M., Hermansson C., Lindberg M. Quality of life, health-state utilities and willingness to pay in patients with psoriasis and atopic eczema. Br J Dermatol. 141:1999;1067-1075
33. Gupta M.A., Gupta A.K., Watteel G.N. Perceived deprivation of social touch in psoriasis is associated with greater psychological morbidity: an index of the stigma experience in dermatologic disorders. Cutis. 61:1998;339-342
34. Ginsburg I.A., Link B.G. Psychosocial consequences of rejection and stigma feelings in psoriatic patients. Int J Dermatol. 32(8):1993;587-591
35. Gupta M.A., Gupta A.K. Psoriasis and sex: a study of moderately to severely affected patients. Int J Dermatol. 36:1997;259-262
36. Fortune D.G., Main C.J., O'Sullivan T.M., Griffiths C.E.M. Quality of life in patients with psoriasis: the contribution of clinical variables and psoriasis specific stress. Br J Dermatol. 137:1997;755-760
37. Lebwohl M., Tan M.H. Commentary: psoriasis and stress. Lancet. 350:1998;82
38. Gupta M.A., Gupta A.K. Age and gender differences in the impact of psoriasis on quality of life. Int J Dermatol. 34(10):1995;700-703
39. Richards H.L., Fortune D.G., O'Sullivan T.M., Main C.J., Griffiths C.E.M. Patients with psoriasis and their compliance with medication. J Am Acad Dermatol. 41(4):1999;581-583
40. Perrott S.B., Murray A.H., Lowe J., Mathieson C.M. The psychosocial impact of psoriasis: physical severity, quality of life, and stigmatization. Physiol Behav. 70:2000;567-571
41. Rapp S.R., Cottrell C.A., Leary M.R. Social coping strategies associated with quality of life decrements among psoriasis patients. Br J Dermatol. 145:2001;610-616
42. Wahl A., Hanestad B.R., Wiklund I., Moum T. Coping and quality of life in patients with psoriasis. Qual Life Res. 8:1999;427-433
43. Scharloo M., Kaptein A.A., Weinman J., Bergman W., Vermeer B.J., Rooijmans H.G.M. Patient's illness perceptions and coping as predictors of functional status in psoriasis: a one-year follow up. Br J Dermatol. 142:2000;899-907
44. Feldman S.R., Fleischer A.B., Reboussin D.M., Rapp S.R., Bradham D.D., Exum M.L., et al. The economic impact of psoriasis increases with psoriasis severity. J Am Acad Dermatol. 37:1997;564-569
45. Kirby B., Richards H.L., Woo P., Hindle E., Main C.J., Griffiths C.E.M. Physical and psychologic measures are necessary to assess overall psoriasis severity. J Am Acad Dermatol. 45:2001;72-76